|
US598621A
(en)
|
|
1898-02-08 |
|
Refrigerating apparatus |
|
US605344A
(en)
|
|
1898-06-07 |
|
sabin |
|
US630517A
(en)
|
1899-04-05 |
1899-08-08 |
Edward L Perry |
Composition for printers' inking-rollers.
|
|
NL124473C
(cg-RX-API-DMAC7.html)
|
1960-07-26 |
|
|
|
|
GB1047518A
(en)
|
1963-06-11 |
1966-11-02 |
Glaxo Lab Ltd |
17ª-monoesters of 11,17,21-trihydroxy steroid compounds
|
|
NL128816C
(cg-RX-API-DMAC7.html)
|
1965-04-22 |
|
|
|
|
GB1158492A
(en)
|
1966-02-09 |
1969-07-16 |
Boots Pure Drug Co Ltd |
Improvements in Acylated Steroids
|
|
GB1200886A
(en)
|
1966-09-23 |
1970-08-05 |
Allen & Hanburys Ltd |
Phenylaminoethanol derivatives
|
|
US3937838A
(en)
|
1966-10-19 |
1976-02-10 |
Aktiebolaget Draco |
Orally active bronchospasmolytic compounds and their preparation
|
|
US3639434A
(en)
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
|
US3780177A
(en)
|
1967-06-16 |
1973-12-18 |
Warner Lambert Co |
17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
|
|
CH540244A
(de)
|
1967-11-17 |
1973-08-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung neuer Halogenpregnadiene
|
|
GB1253831A
(en)
|
1968-01-19 |
1971-11-17 |
Glaxo Lab Ltd |
9alpha,21-DIHALOPREGNANE COMPOUNDS
|
|
US3700681A
(en)
|
1971-02-16 |
1972-10-24 |
Pfizer |
2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
|
|
US3947478A
(en)
|
1972-01-12 |
1976-03-30 |
Akzona Incorporated |
Alkylated 3,20-diketo-Δ4 -steroids of the pregnane series
|
|
US3994974A
(en)
|
1972-02-05 |
1976-11-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
α-Aminomethylbenzyl alcohol derivatives
|
|
SE378109B
(cg-RX-API-DMAC7.html)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US3992534A
(en)
*
|
1972-05-19 |
1976-11-16 |
Ab Bofors |
Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
|
|
SE378110B
(cg-RX-API-DMAC7.html)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
FR2231374B1
(cg-RX-API-DMAC7.html)
|
1973-05-30 |
1976-10-22 |
Jouveinal Sa |
|
|
US4098804A
(en)
|
1973-05-30 |
1978-07-04 |
Jouveinal S.A. |
Esters of 21-thiol prednisone and prednisolone
|
|
US4011258A
(en)
|
1973-06-21 |
1977-03-08 |
Aktiebolaget Draco |
Orally active bronchospasmolytic compounds
|
|
ZA744259B
(en)
|
1973-08-17 |
1975-06-25 |
American Cyanamid Co |
Topical steroid
|
|
US3980778A
(en)
|
1973-10-25 |
1976-09-14 |
The Upjohn Company |
Anti-inflammatory steroid
|
|
NL7502252A
(nl)
|
1974-02-27 |
1975-08-29 |
Pierrel Spa |
Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
|
|
DE2655570A1
(de)
|
1975-12-12 |
1977-06-16 |
Ciba Geigy Ag |
Neue polyhalogensteroide und verfahren zu ihrer herstellung
|
|
US4076708A
(en)
|
1976-12-22 |
1978-02-28 |
Schering Corporation |
Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby
|
|
US4124707A
(en)
|
1976-12-22 |
1978-11-07 |
Schering Corporation |
7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
|
|
US4081541A
(en)
|
1976-12-28 |
1978-03-28 |
Rorer Italiana S.P.A. |
Steroid derivatives
|
|
DE2735110A1
(de)
|
1977-08-04 |
1979-02-15 |
Hoechst Ag |
Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
|
|
JPS6040439B2
(ja)
|
1978-03-29 |
1985-09-11 |
大正製薬株式会社 |
ヒドロコルチゾン誘導体
|
|
BE887518A
(fr)
|
1980-02-15 |
1981-08-13 |
Glaxo Group Ltd |
Cartothioates d'androstanes
|
|
DE3163871D1
(en)
|
1980-07-09 |
1984-07-05 |
Draco Ab |
1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
|
|
US4298604B1
(en)
|
1980-10-06 |
1998-12-22 |
Schering Corp |
Clotrimazole-betamethasone dipropionate combination
|
|
CY1359A
(en)
|
1981-02-02 |
1987-08-07 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
|
DE3133081A1
(de)
|
1981-08-18 |
1983-03-10 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
|
|
US4472392A
(en)
|
1983-01-21 |
1984-09-18 |
The Upjohn Company |
Sulfonate containing ester prodrugs of corticosteroids
|
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
CA1240708A
(en)
|
1983-11-15 |
1988-08-16 |
Johannes K. Minderhoud |
Process for the preparation of hydrocarbons
|
|
SE8800207D0
(sv)
|
1988-01-22 |
1988-01-22 |
Kabivitrum Ab |
Nya aminer, deras anvendning och framstellning
|
|
CA1326662C
(en)
|
1988-03-09 |
1994-02-01 |
Yutaka Mizushima |
11.beta.,17.,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(e,e)-3,7,11-trimethyl-2,6,10-dodecatrienoate]
|
|
US5278156A
(en)
|
1988-03-09 |
1994-01-11 |
Kuraray Co., Ltd. |
11-beta, 17-alpha, 21-trihydroxy-1, 4-pregnadiene-3, 20 21-[(E-E)-3,7, 11-trimethyl-2,6,10-dodecatrienoate]
|
|
US5001160A
(en)
|
1988-04-28 |
1991-03-19 |
Marion Laboratories, Inc. |
1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
|
|
GB8906166D0
(en)
|
1989-03-17 |
1989-05-04 |
Pfizer Ltd |
Therapeutic agents
|
|
US5281601A
(en)
|
1989-12-12 |
1994-01-25 |
Pfizer Inc. |
Muscarinic receptor antagonists
|
|
GB8928042D0
(en)
|
1989-12-12 |
1990-02-14 |
Pfizer Ltd |
Muscarinic receptor antagonists
|
|
GR1001529B
(el)
|
1990-09-07 |
1994-03-31 |
Elmuquimica Farm Sl |
Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
|
|
HU213401B
(en)
|
1990-09-10 |
1997-06-30 |
Schering Corp |
Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it
|
|
GB9020051D0
(en)
|
1990-09-13 |
1990-10-24 |
Pfizer Ltd |
Muscarinic receptor antagonists
|
|
US6127353A
(en)
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
GB9202443D0
(en)
|
1992-02-05 |
1992-03-18 |
Fujisawa Pharmaceutical Co |
A novel substituted-acetamide compound and a process for the preparation thereof
|
|
FI100051B
(fi)
|
1992-02-18 |
1997-09-15 |
Favorit Oy |
Kompostori
|
|
JP3429338B2
(ja)
|
1992-07-27 |
2003-07-22 |
杏林製薬株式会社 |
新規なアリールグリシンアミド誘導体及びその製造法
|
|
JPH06135958A
(ja)
|
1992-10-28 |
1994-05-17 |
Tanabe Seiyaku Co Ltd |
ベンゾシクロヘプテン誘導体及びその製法
|
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
NO2005012I1
(no)
|
1994-12-28 |
2005-06-06 |
Debio Rech Pharma Sa |
Triptorelin og farmasoytisk akseptable salter derav
|
|
DZ1966A1
(fr)
|
1995-02-06 |
2002-10-15 |
Astra Ab |
Combinaison pharmaceutique nouvelle.
|
|
US5750540A
(en)
|
1995-04-28 |
1998-05-12 |
Banyu Pharmaceutical Co., Ltd. |
1,4-di-substituted piperidine derivatives
|
|
ES2172583T3
(es)
|
1995-06-06 |
2002-10-01 |
Pfizer |
5,6-dihidro-9h-pirazol(3,4-c)-1,2,4-triazol(4,3-alfa)piridinas triciclicas.
|
|
CA2179574A1
(en)
|
1995-06-26 |
1996-12-27 |
Tomomi Okada |
Substituted piperidine derivative and medicine comprising the same
|
|
ATE205490T1
(de)
|
1995-10-13 |
2001-09-15 |
Banyu Pharma Co Ltd |
Substituierte heteroaromatische derivate
|
|
AU2793197A
(en)
|
1996-05-31 |
1998-01-05 |
Banyu Pharmaceutical Co., Ltd. |
1,4-disubstituted piperidine derivatives
|
|
US5976573A
(en)
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
|
PE92198A1
(es)
|
1996-08-01 |
1999-01-09 |
Banyu Pharma Co Ltd |
Derivados de 1,4-piperidina disustituida que contienen fluor
|
|
PL189641B1
(pl)
|
1996-11-11 |
2005-09-30 |
Altana Pharma Ag |
Benzonaftyrydyny, środki farmaceutyczne je zawierające oraz zastosowanie benzonaftyrydyn
|
|
KR20000057548A
(ko)
|
1996-12-13 |
2000-09-25 |
알프레드 엘. 미첼슨 |
광학적 전송물질 및 결합재
|
|
PL198983B1
(pl)
|
1998-04-28 |
2008-08-29 |
Elbion Ag |
Nowe hydroksyindole, ich zastosowanie jako inhibitorów fosfodiesterazy 4 oraz sposoby ich wytwarzania
|
|
ITMI981670A1
(it)
|
1998-07-21 |
2000-01-21 |
Zambon Spa |
Derivati ftalazinici inibitori della fosfodiesterasi 4
|
|
GB9824160D0
(en)
|
1998-11-04 |
1998-12-30 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
UA73543C2
(uk)
|
1999-12-07 |
2005-08-15 |
Тераванс, Інк. |
Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
|
|
DE60021282T2
(de)
|
1999-12-07 |
2006-05-18 |
Theravance, Inc., South San Francisco |
Carbamat-derivate als muscarin-rezeptor antonisten
|
|
IL152701A0
(en)
|
2000-05-25 |
2003-06-24 |
Hoffmann La Roche |
Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
|
|
US20020052312A1
(en)
*
|
2000-05-30 |
2002-05-02 |
Reiss Theodore F. |
Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
|
|
US20030199494A1
(en)
|
2000-06-14 |
2003-10-23 |
Paul Evans |
1,2,3,5-tetrahydrobenzo'c!azepin-4-one derivatives having muscarinic antagonist activity
|
|
KR100751981B1
(ko)
|
2000-06-27 |
2007-08-28 |
라보라토리오스 살바트, 에스.에이. |
아릴알킬아민으로부터 유도된 카바메이트
|
|
DE10050994A1
(de)
|
2000-10-14 |
2002-04-18 |
Boehringer Ingelheim Pharma |
Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
|
|
DE10050995A1
(de)
|
2000-10-14 |
2002-04-18 |
Boehringer Ingelheim Pharma |
Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE60121813T2
(de)
|
2000-12-28 |
2007-09-20 |
Almirall Ag |
Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten
|
|
AU2002345266B2
(en)
*
|
2002-07-08 |
2009-07-02 |
Ranbaxy Laboratories Limited |
3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
|
|
JP2006522787A
(ja)
*
|
2003-04-11 |
2006-10-05 |
ランバクシー ラボラトリーズ リミテッド |
ムスカリン様受容体アンタゴニストとしてのアザビシクロ誘導体
|
|
CA2522666A1
(en)
*
|
2003-04-18 |
2004-10-28 |
Pharmacia & Upjohn Company Llc |
Combination therapies for chronic obstructive pulmonary disease (copd)
|
|
US7825147B2
(en)
|
2003-08-29 |
2010-11-02 |
Ranbaxy Laboratories Limited |
Inhibitors of phosphodiesterase type-IV
|
|
EP1713471B1
(en)
*
|
2004-02-06 |
2012-01-18 |
MEDA Pharma GmbH & Co. KG |
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
|
|
WO2005092341A1
(en)
*
|
2004-03-22 |
2005-10-06 |
Ranbaxy Laboratories Limited |
Combination therapy for lower urinary tract symptoms
|
|
WO2006003587A2
(en)
*
|
2004-07-01 |
2006-01-12 |
Ranbaxy Laboratories Limited |
Solid oral dosage forms of azabicyclo derivatives
|
|
EP1828126A1
(en)
*
|
2004-12-15 |
2007-09-05 |
Ranbaxy Laboratories Limited |
Acid addition salts of muscarinic receptor antagonists
|
|
WO2006117754A1
(en)
*
|
2005-05-03 |
2006-11-09 |
Ranbaxy Laboratories Limited |
3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
|
|
BRPI0617673C1
(pt)
*
|
2005-10-19 |
2012-05-22 |
Ranbaxy Lab Ltd |
composições de inibidores de fosfodiesterase do tipo iv
|